$CYDY CytoDyn Files FDA-Suggested Modifications To IND And Protocol For Phase 2 Clinical Trial For COVID-19 Patients With Mild To Moderate Indications And A Second Randomized Protocol For All #COVID?19 Patients In Severe Condition Will Be Filed Next Week Per FDA Recommendation